ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2022

ANMCO statement on the use of sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a practical guide for a streamlined implementation.

Stefania Angela Di Fusco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.